First Time Loading...

Oric Pharmaceuticals Inc
NASDAQ:ORIC

Watchlist Manager
Oric Pharmaceuticals Inc Logo
Oric Pharmaceuticals Inc
NASDAQ:ORIC
Watchlist
Price: 9.71 USD 2%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

ORIC Price Targets Summary
Oric Pharmaceuticals Inc

Wall Street analysts forecast ORIC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORIC is 19.53 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

ORIC Lowest Forecast
Wall Street Target
15.15 USD
56% Upside
ORIC Average Forecast
Wall Street Target
19.53 USD
101% Upside
ORIC Highest Forecast
Wall Street Target
26.25 USD
170% Upside
Lowest
Price Target
15.15 USD
56% Upside
Average
Price Target
19.53 USD
101% Upside
Highest
Price Target
26.25 USD
170% Upside

ORIC Last Price Targets
Oric Pharmaceuticals Inc

The latest public price target was made on Mar 21, 2024 by Robert Burns from H.C. Wainwright , who expects ORIC stock to rise by 116% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Robert Burns
H.C. Wainwright
21 USD
Upside 116%
1 month ago
Mar 21, 2024
ORIC Pharamceuticals (ORIC) PT Raised to $21 at H.C. Wainwright following 2023 results
StreetInsider
David Nierengarten
Wedbush
20 USD
Upside 106%
1 month ago
Mar 12, 2024
These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results
Benzinga
Matthew Biegler
Oppenheimer
17 USD
Upside 75%
1 month ago
Mar 12, 2024
ORIC Pharamceuticals (ORIC) PT Raised to $17 at Oppenheimer, 'Executing On Multiple Fronts'
StreetInsider
Robert Burns
H.C. Wainwright
Price Target 21 USD
Upside/Downside 116%
View Source
David Nierengarten
Wedbush
Price Target 20 USD
Upside/Downside 106%
View Source
Matthew Biegler
Oppenheimer
Price Target 17 USD
Upside/Downside 75%
View Source
Oric Pharmaceuticals Inc Competitors:
Price Targets
ABOS
Acumen Pharmaceuticals Inc
274% Upside
688363
Bloomage Biotechnology Corp Ltd
31% Upside
REGN
Regeneron Pharmaceuticals Inc
12% Upside
BMRN
Biomarin Pharmaceutical Inc
32% Upside
ABOS
Acumen Pharmaceuticals Inc
274% Upside
688363
Bloomage Biotechnology Corp Ltd
31% Upside
REGN
Regeneron Pharmaceuticals Inc
12% Upside
BMRN
Biomarin Pharmaceutical Inc
32% Upside
ZYME
Zymeworks Inc
76% Upside
S
002880
Shenzhen Weiguang Biological Products Co Ltd
39% Upside
PBYI
Puma Biotechnology Inc
9% Downside
TWST
Twist Bioscience Corp
2% Upside

Revenue
Forecast

Revenue Estimate
Oric Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Oric Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Oric Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
What are analyst estimates?

See Also

Summary
ORIC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORIC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORIC stock valuation using valuation multiples.
Wall Street Estimates
ORIC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORIC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORIC's stock price target?
Price Target
19.53 USD

According to Wall Street analysts, the average 1-year price target for ORIC is 19.53 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.